CILcare will be attending the 16th Annual Discovery on Target on September 25-28, 2018 in Boston. Meet Sylvie COSNIER-PUCHEU, Ph.D, CSO, with her presentation on Preclinical Strategies for Evaluating Treatment Efficacy to Prevent or Cure Auditory Disorders on 27th of September at 3:55 PM.
We invite you to come and discover our poster describing role of melatonin in the prevention of noise-induced hearing loss.
Hearing loss is the most common form of sensory impairment in humans. Preventing noise-induced hearing loss (NIHL) by antioxidants is based on the hypothesis that generation of reactive oxygen species is one of the causes of NIHL. Melatonin, which is a secretary product of the pineal gland, is a powerful antioxidant and a free radical scavenger.
Read CILcare’s publications and scientific journal articles related to hearing disorders.
The 16th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets,” will once again gather over 1,300 drug discovery professionals in Boston, MA, this September 25-28, 2018. The event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.